Markel Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39M Buy
82,430
+1,750
+2% +$881K 0.33% 63
2025
Q4
$37.7M Buy
80,680
+5,467
+7% +$2.54M 0.3% 61
2025
Q3
$32.1M Buy
75,213
+6,250
+9% +$2.42M 0.26% 70
2025
Q2
$26.4M Buy
68,963
+6,962
+11% +$2.51M 0.22% 74
2025
Q1
$21.4M Buy
62,001
+5,421
+10% +$1.74M 0.19% 77
2024
Q4
$17M Buy
56,580
+5,650
+11% +$1.97M 0.15% 86
2024
Q3
$20.7M Buy
50,930
+15,825
+45% +$5.79M 0.19% 81
2024
Q2
$11.3M Buy
35,105
+13,673
+64% +$4.44M 0.11% 95
2024
Q1
$7.15M Buy
21,432
+7,291
+52% +$2.23M 0.07% 108
2023
Q4
$3.83M Buy
14,141
+6,091
+76% +$1.51M 0.04% 112
2023
Q3
$1.98M Buy
+8,050
New +$2.2M 0.02% 121

Other funds holding HCA

Markel Group's HCA Position: Q1 2026 in Review

Markel Group increased its HCA Healthcare (HCA) stake by 2.2% in Q1 2026, buying an estimated $881K and bringing the position to 82,430 shares worth $39M. The position accounts for 0.33% of the portfolio, ranked #63.

Markel Group first reported a position in HCA in Q3 2023 and has held it in 11 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Markel Group held 82,430 shares of HCA Healthcare worth $39M as of Q1 2026.
  • Markel Group bought 1,750 HCA Healthcare shares in Q1 2026, an estimated $881K.
  • HCA Healthcare made up 0.33% of Markel Group's portfolio in Q1 2026, its #63 holding.
  • Markel Group first reported a position in HCA Healthcare in Q3 2023 and has held it in 11 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Markel Group's 13F filing for Q1 2026, filed 1 May 2026.